Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland.
Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland; Vital-IT, Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
Mol Metab. 2020 Jul;37:100993. doi: 10.1016/j.molmet.2020.100993. Epub 2020 Apr 13.
Glucose-stimulated insulin secretion is a critical function in the regulation of glucose homeostasis, and its deregulation is associated with the development of type 2 diabetes. Here, we performed a genetic screen using islets isolated from the BXD panel of advanced recombinant inbred (RI) lines of mice to search for novel regulators of insulin production and secretion.
Pancreatic islets were isolated from 36 RI BXD lines and insulin secretion was measured following exposure to 2.8 or 16.7 mM glucose with or without exendin-4. Islets from the same RI lines were used for RNA extraction and transcript profiling. Quantitative trait loci (QTL) mapping was performed for each secretion condition and combined with transcriptome data to prioritize candidate regulatory genes within the identified QTL regions. Functional studies were performed by mRNA silencing or overexpression in MIN6B1 cells and by studying mice and islets with beta-cell-specific gene inactivation.
Insulin secretion under the 16.7 mM glucose plus exendin-4 condition was mapped significantly to a chromosome 2 QTL. Within this QTL, RNA-Seq data prioritized Crat (carnitine O-acetyl transferase) as a strong candidate regulator of the insulin secretion trait. Silencing Crat expression in MIN6B1 cells reduced insulin content and insulin secretion by ∼30%. Conversely, Crat overexpression enhanced insulin content and secretion by ∼30%. When islets from mice with beta-cell-specific Crat inactivation were exposed to high glucose, they displayed a 30% reduction of insulin content as compared to control islets. We further showed that decreased Crat expression in both MIN6B1 cells and pancreatic islets reduced the oxygen consumption rate in a glucose concentration-dependent manner.
We identified Crat as a regulator of insulin secretion whose action is mediated by an effect on total cellular insulin content; this effect also depends on the genetic background of the RI mouse lines. These data also show that in the presence of the stimulatory conditions used the insulin secretion rate is directly related to the insulin content.
葡萄糖刺激的胰岛素分泌是调节葡萄糖稳态的关键功能,其失调与 2 型糖尿病的发展有关。在这里,我们使用来自 BXD 面板的先进重组近交 (RI) 系小鼠的胰岛进行了遗传筛选,以寻找胰岛素产生和分泌的新调节剂。
从 36 个 RI BXD 系中分离胰岛,并在暴露于 2.8 或 16.7 mM 葡萄糖以及外泌素-4 时测量胰岛素分泌。使用相同的 RI 系胰岛进行 RNA 提取和转录谱分析。对每种分泌条件进行数量性状基因座 (QTL) 作图,并将其与转录组数据相结合,优先考虑在所鉴定的 QTL 区域内的候选调节基因。通过在 MIN6B1 细胞中进行 mRNA 沉默或过表达以及研究具有β细胞特异性基因失活的小鼠和胰岛来进行功能研究。
16.7 mM 葡萄糖加外泌素-4 条件下的胰岛素分泌显著映射到染色体 2 QTL。在这个 QTL 内,RNA-Seq 数据将 Crat(肉碱 O-乙酰转移酶)优先作为胰岛素分泌特征的强候选调节剂。在 MIN6B1 细胞中沉默 Crat 表达会降低胰岛素含量和胰岛素分泌约 30%。相反,Crat 过表达可使胰岛素含量和分泌增加约 30%。当用高葡萄糖暴露时,具有β细胞特异性 Crat 失活的小鼠胰岛的胰岛素含量降低了 30%。我们进一步表明,MIN6B1 细胞和胰腺胰岛中 Crat 表达的降低以葡萄糖浓度依赖的方式降低了耗氧量。
我们将 Crat 鉴定为胰岛素分泌的调节剂,其作用是通过对总细胞胰岛素含量的影响来介导的;这种作用还取决于 RI 小鼠系的遗传背景。这些数据还表明,在使用的刺激条件下,胰岛素分泌率与胰岛素含量直接相关。